Advanced search
Publication Cover
Regenerative Medicine Volume 9, 2014 - Issue 1
Submit an article Journal homepage
245
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Injectable Gel Graft for Bone Defect Repair

Josephine Fang1 Division of Plastic & Reconstructive Surgery, Department of Surgery, Keck Medical School, University of Southern California, 1333 San Pablo St, BMT 302A, Los Angeles, CA90089-9112, USAView further author information
,
Zhi Yang1 Division of Plastic & Reconstructive Surgery, Department of Surgery, Keck Medical School, University of Southern California, 1333 San Pablo St, BMT 302A, Los Angeles, CA90089-9112, USAView further author information
,
ShihJye Tan2 Department of Biomedical Engineering, Viterbi School of Engineering, University of Southern California, Los Angeles, CA, USAView further author information
,
Charisse Tayag1 Division of Plastic & Reconstructive Surgery, Department of Surgery, Keck Medical School, University of Southern California, 1333 San Pablo St, BMT 302A, Los Angeles, CA90089-9112, USAView further author information
,
Marcel E Nimni1 Division of Plastic & Reconstructive Surgery, Department of Surgery, Keck Medical School, University of Southern California, 1333 San Pablo St, BMT 302A, Los Angeles, CA90089-9112, USAView further author information
,
Mark Urata1 Division of Plastic & Reconstructive Surgery, Department of Surgery, Keck Medical School, University of Southern California, 1333 San Pablo St, BMT 302A, Los Angeles, CA90089-9112, USAView further author information
&
Bo Han2 Department of Biomedical Engineering, Viterbi School of Engineering, University of Southern California, Los Angeles, CA, USA;1 Division of Plastic & Reconstructive Surgery, Department of Surgery, Keck Medical School, University of Southern California, 1333 San Pablo St, BMT 302A, Los Angeles, CA90089-9112, USACorrespondence[email protected]
View further author information
 show all
Pages 41-51 | Published online: 18 Dec 2013

References

  • Burchardt H , BusbeeGA 3rd, Enneking WF. Repair of experimental autologous grafts of cortical bone. J. Bone Joint Surg. Am.57(6) , 814–819 (1975).
  • Graham JM , PhelpsPD, MichaelsL. Congenital malformations of the ear and cochlear implantation in children: review and temporal bone report of common cavity. J. Laryngol. Otol.114 , 1–14 (1999).
  • Szpalski C , BarrJ, WetterauM, SaadehPB, WarrenSM. Cranial bone defects: current and future strategies. Neurosurg. Focus29(6) , e8 (2010).
  • Ginebra MP , CanalC, EspanolM, PastorinoD, MontufarEB. Calcium phosphate cements as drug delivery materials. Adv. Drug Deliv. Rev.64(12) , 1090–1110 (2012).
  • Ambrosio L , GuarinoV, SanginarioV et al. Injectable calcium-phosphate-based composites for skeletal bone treatments. Biomed. Mater. 7(2) , 024113 (2012).
  • Kurashina K , KuritaH, HiranoM, KotaniA, KleinC, De Groot K. In vivo study of calcium phosphate cements: implantation of an α-tricalcium phosphate/dicalcium phosphate dibasic/tetracalcium phosphate monoxide cement paste. Biomaterials18(7) , 539–543 (1997).
  • Dumas JE , BrownBaerPB, PrietoEM et al. Injectable reactive biocomposites for bone healing in critical-size rabbit calvarial defects. Biomed. Mater. 7(2) , 024112 (2012).
  • Bae SE , ChoiJ, JoungYK, ParkK, HanDK. Controlled release of bone morphogenetic protein (BMP)-2 from nanocomplex incorporated on hydroxyapatite-formed titanium surface. J. Control. Release160(3) , 676–684 (2012).
  • McKay WF , PeckhamSM, BaduraJM. A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE® Bone Graft). Int. Orthop.31(6) , 729–734 (2007).
  • Park YJ , KimKH, LeeJY et al. Immobilization of bone morphogenetic protein-2 on a nanofibrous chitosan membrane for enhanced guided bone regeneration. Biotechnol. Appl. Biochem. 43(1) , 17–24 (2006).
  • Liu Y , HuseRO, de Groot K, Buser D, Hunziker EB. Delivery mode and efficacy of BMP-2 in association with implants. J. Dent. Res.86(1) , 84–89 (2007).
  • Liu Y , LuY, TianX et al. Segmental bone regeneration using an rhBMP-2-loaded gelatin/nanohydroxyapatite/fibrin scaffold in a rabbit model. Biomaterials 30(31) , 6276–6285 (2009).
  • Zhang Q , HeQF, ZhangTH, YuXL, LiuQ, DengFL. Improvement in the delivery system of bone morphogenetic protein-2: a new approach to promote bone formation. Biomed. Mater.7(4) , 045002 (2012).
  • Kuwahara K , YangZ, SlackGC, NimniME, HanB. Cell delivery using an injectable and adhesive transglutaminase–gelatin gel. Tissue Eng. Part C Methods16(4) , 609–618 (2009).
  • Kuwahara K , FangJY, YangZ, HanB. Enzymatic crosslinking and degradation of gelatin as a switch for bone morphogenetic protein-2 activity. Tissue Eng. Part A17(23–24) , 2955–2964 (2011).
  • Dinnella C , GargaroMT, RossanoR, MonteleoneE. Spectrophotometric assay using o-phtaldialdehyde for the determination of transglutaminase activity on casein. Food Chem.78(3) , 363–368 (2002).
  • Bradford MM . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem.72(1) , 248–254 (1976).
  • Han B , TangB, NimniME. Quantitative and sensitive in vitro assay for osteoinductive activity of demineralized bone matrix. J. Orthop. Res.21(4) , 648–654 (2003).
  • Maxová H , BacakovaL, LisáV et al. Production of proteolytic enzymes in mast cells, fibroblasts, vascular smooth muscle and endothelial cells cultivated under normoxic or hypoxic conditions. Phys. Res. 59 , 711–719 (2010).
  • Chau D , CollighanRJ, VerderioEA, AddyVL, GriffinM. The cellular response to transglutaminase-crosslinked collagen. Biomaterials26(33) , 6518–6529 (2005).
  • Tsuji K , BandyopadhyayA, HarfeBD et al. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat. Genet. 38(12) , 1424–1429 (2006).
  • Takagi K , UristMR. The reaction of the dura to bone morphogenetic protein (BMP) in repair of skull defects. Ann. Surg.196(1) , 100–109 (1982).
  • Schmoekel H , SchenseJC, WeberFE et al. Bone healing in the rat and dog with nonglycosylated BMP-2 demonstrating low solubility in fibrin matrices. J. Orthop. Res. 22(2) , 376–381 (2004).
  • Young S , WongM, TabataY, MikosAG. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J. Control. Release109(1) , 256–274 (2005).
  • Yung CW , WuLQ, TullmanJA, PayneGF, BentleyWE, BarbariTA. Transglutaminase crosslinked gelatin as a tissue engineering scaffold. J. Biomed. Mater. Res. A83(4) , 1039–1046 (2007).
  • Chen T , SmallDA, McDermottMK, BentleyWE, PayneGF. Enzymatic methods for in situ cell entrapment and cell release. Biomacromolecules4(6) , 1558–1563 (2003).
  • Folk JE . Mechanism and basis for specificity of transglutaminase-catalyzed e-(c-glutamyl) lysine bond formation. Adv. Enzymol. Relat. Areas Mol. Biol.54 , 1–56 (1983).
  • Lee JW , LeeS, LeeSH et al. Improved spinal fusion efficacy by long-term delivery of bone morphogenetic protein-2 in a rabbit model. Acta Orthop. 82(6) , 756–760 (2011).
  • Zara JN , SiuRK, ZhangX et al. High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo. Tissue Eng. Part A 17(9–10) , 1389–1399 (2011).
  • Zhou H , QianJ, WangJ et al. Enhanced bioactivity of bone morphogenetic protein-2 with low dose of 2-N, 6-O-sulfated chitosan in vitro and in vivo. Biomaterials 30(9) , 1715–1724 (2009).
  • Kinsella CR , BykowskiMR, LinAY et al. BMP-2-mediated regeneration of large-scale cranial defects in the canine: an examination of different carriers. Plast. Reconstr. Surg. 127(5) , 1865–1873 (2011).
  • Fontana A , SpolaoreB, MeroA, VeroneseFM. Site-specific modification and PEGylation of pharmaceutical proteins mediated by transglutaminase. Adv. Drug Deliv. Rev.60(1) , 13–28 (2008).
  • Sato H . Enzymatic procedure for site-specific pegylation of proteins. Adv. Drug Deliv. Rev.54(4) , 487–504 (2002).
  • Ito A , MaseA, TakizawaY et al. Transglutaminase-mediated gelatin matrices incorporating cell adhesion factors as a biomaterial for tissue engineering. J. Biosci. Bioeng. 95(2) , 196–199 (2003).
  • Yasko AW , LaneJM, FellingerEJ, RosenV, WozneyJM, WangEA. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. J. Bone Joint Surg. Am.74(5) , 659 (1992).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.